Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Dana-Farber Cancer Institute
Nov 30, 2023, 15:29 |
Drugs
David Steensma: Randomized STIMULUS-MDS1 trial didn't meet endpoint
David Steensma, Associate professor at Harvard Medical School and faculty member in the leukemia program…
Nov 30, 2023, 15:25 |
Blog
Monica M. Bertagnolli: One of my priorities is ensuring all people are represented in clinical trials
Monica M. Bertagnolli shared a post on X/Twitter: "One of my priorities is ensuring all…
Nov 29, 2023, 16:26 |
Blog
Top 10 abstracts to keep an eye on for SABCS 23 by Paolo Tarantino
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on X/Twitter: "10 days to…
Nov 27, 2023, 17:43 |
Blog
Paolo Tarantino: Can we get rid of the anthracyclines from the KN522 regimen?
Paolo Tarantino, Researcher at the European Institute of Oncology and clinical research fellow at the…
Nov 25, 2023, 18:19 |
Blog
Dong-Woo Kang: Honored and excited to receive funding from WCRF/AICR
Dong-Woo Kang, an Instructor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute recently…
Nov 25, 2023, 17:16 |
Blog
Toni Choueiri: Looking forward to speak at this SABCS23 session about biomarkers of immunotherapy toxicity
Toni Choueiri, Director of the Lank Center for Genitourinary Cancers and the Medical Director of…
Nov 23, 2023, 01:31 |
Blog
Sarah Waliany: The incomparable Sumanta K. Pal on cardiovascular AEs associated w/ mRCC treatments
Sarah Waliany, Hematology and Oncology Fellow at Dana-Farber Cancer Institute, made the following post on…
Nov 22, 2023, 03:19 |
Insight
Monica Bertagnolli: There has never been more potential for scientific progress!
Quoting Monica Bertagnolli on X/Twitter: "The more I learn during my first few days as the…
Nov 20, 2023, 04:08 |
Insight
Adam C Palmer: You don’t need ‘1+1 makes 3’ if you can have ‘5+5 makes 10’
David Steensma, Chief Medical Officer at Ajax Therapeutics, and Anthony Letai, Professor at Dana-Farber Cancer…
Nov 20, 2023, 03:18 |
Career
Toni K. Choueiri: I am honored to be running as one of the candidates for the Board of Directors Undesignated Member seats
Toni K. Choueiri shared on LinkedIn: "Voting for the ASCO Election is now open. I…
68
69
70
71
72
All:
749
Posts:
691 - 700
Top 100 Xfluencers in Pediatric Hematology/Oncology: Key Opinion Leaders to follow on X (Twitter) in 2024
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube